307 related articles for article (PubMed ID: 23597420)
21. Hippocampal avoidance prophylactic cranial irradiation (HA-PCI) for small cell lung cancer reduces hippocampal atrophy compared to conventional PCI.
de Ruiter MB; Groot PFC; Deprez S; Pullens P; Sunaert S; de Ruysscher D; Schagen SB; Belderbos J
Neuro Oncol; 2023 Jan; 25(1):167-176. PubMed ID: 35640975
[TBL] [Abstract][Full Text] [Related]
22. Prophylactic Cranial Irradiation for Limited-Stage Small-Cell Lung Cancer: Survey of US Radiation Oncologists on Current Practice Patterns.
Farrell MJ; Yahya JB; Degnin C; Chen Y; Holland JM; Henderson MA; Jaboin JJ; Harkenrider MM; Thomas CR; Mitin T
Clin Lung Cancer; 2018 Jul; 19(4):371-376. PubMed ID: 29559208
[TBL] [Abstract][Full Text] [Related]
23. [Present role of prophylactic cranial irradiation].
Le Péchoux C; Al Mohkles H; Dhermain F
Bull Cancer; 2013 Jan; 100(1):35-43. PubMed ID: 23306141
[TBL] [Abstract][Full Text] [Related]
24. Neurocognitive function in patients with small cell lung cancer : effect of prophylactic cranial irradiation.
Grosshans DR; Meyers CA; Allen PK; Davenport SD; Komaki R
Cancer; 2008 Feb; 112(3):589-95. PubMed ID: 18098269
[TBL] [Abstract][Full Text] [Related]
25. Phase 3 Randomized Trial of Prophylactic Cranial Irradiation With or Without Hippocampus Avoidance in SCLC (NCT01780675).
Belderbos JSA; De Ruysscher DKM; De Jaeger K; Koppe F; Lambrecht MLF; Lievens YN; Dieleman EMT; Jaspers JPM; Van Meerbeeck JP; Ubbels F; Kwint MH; Kuenen MA; Deprez S; De Ruiter MB; Boogerd W; Sikorska K; Van Tinteren H; Schagen SB
J Thorac Oncol; 2021 May; 16(5):840-849. PubMed ID: 33545387
[TBL] [Abstract][Full Text] [Related]
26. Study protocol: watchful observation of patients with limited small cell lung cancer instead of the PCI-prospective, multi-center one-arm study.
Nawrocki S; Sugajska A
BMC Cancer; 2020 Mar; 20(1):231. PubMed ID: 32188425
[TBL] [Abstract][Full Text] [Related]
27. A prospective evaluation of hippocampal radiation dose volume effects and memory deficits following cranial irradiation.
Ma TM; Grimm J; McIntyre R; Anderson-Keightly H; Kleinberg LR; Hales RK; Moore J; Vannorsdall T; Redmond KJ
Radiother Oncol; 2017 Nov; 125(2):234-240. PubMed ID: 29128167
[TBL] [Abstract][Full Text] [Related]
28. Prophylactic Cranial Irradiation for Patients With Locally Advanced Non-Small-Cell Lung Cancer at High Risk for Brain Metastases.
Park HS; Decker RH; Wilson LD; Yu JB
Clin Lung Cancer; 2015 Jul; 16(4):292-7. PubMed ID: 25499149
[TBL] [Abstract][Full Text] [Related]
29. Rates of Overall Survival and Intracranial Control in the Magnetic Resonance Imaging Era for Patients With Limited-Stage Small Cell Lung Cancer With and Without Prophylactic Cranial Irradiation.
Pezzi TA; Fang P; Gjyshi O; Feng L; Liu S; Komaki R; Lin SH
JAMA Netw Open; 2020 Apr; 3(4):e201929. PubMed ID: 32236532
[TBL] [Abstract][Full Text] [Related]
30. Prophylactic cranial irradiation in extensive disease small-cell lung cancer: short-term health-related quality of life and patient reported symptoms: results of an international Phase III randomized controlled trial by the EORTC Radiation Oncology and Lung Cancer Groups.
Slotman BJ; Mauer ME; Bottomley A; Faivre-Finn C; Kramer GW; Rankin EM; Snee M; Hatton M; Postmus PE; Collette L; Senan S
J Clin Oncol; 2009 Jan; 27(1):78-84. PubMed ID: 19047288
[TBL] [Abstract][Full Text] [Related]
31. Psychophysiological evaluation of short-term neurotoxicity after prophylactic brain irradiation in patients with small cell lung cancer: a study of event related potentials.
Parageorgiou C; Dardoufas C; Kouloulias V; Ventouras E; Uzunoglu N; Vlahos L; Rambavilas A; Christodoulou G
J Neurooncol; 2000 Dec; 50(3):275-85. PubMed ID: 11263508
[TBL] [Abstract][Full Text] [Related]
32. Quality of life in patients with brain metastases using the EORTC QLQ-BN20+2 and QLQ-C15-PAL.
Caissie A; Nguyen J; Chen E; Zhang L; Sahgal A; Clemons M; Kerba M; Arnalot PF; Danjoux C; Tsao M; Barnes E; Holden L; Danielson B; Chow E
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):1238-45. PubMed ID: 22172909
[TBL] [Abstract][Full Text] [Related]
33. Impact of prophylactic cranial irradiation timing on brain relapse rates in patients with stage IIIB non-small-cell lung carcinoma treated with two different chemoradiotherapy regimens.
Topkan E; Parlak C; Kotek A; Yuksel O; Cengiz M; Ozsahin M; Pehlivan B
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):1264-71. PubMed ID: 22172902
[TBL] [Abstract][Full Text] [Related]
34. Cranial prophylactic irradiation in locally advanced non-small cell lung carcinoma: current status and future perspectives.
Topkan E; Yildirim BA; Selek U; Yavuz MN
Oncology; 2009; 76(3):220-8. PubMed ID: 19218826
[TBL] [Abstract][Full Text] [Related]
35. Prophylactic cranial irradiation for patients with locally advanced non-small-cell lung cancer.
Gore EM
Oncology (Williston Park); 2003 Jun; 17(6):775-9; discussion 779-80, 784, 787 passim. PubMed ID: 12846122
[TBL] [Abstract][Full Text] [Related]
36. Treatment Design and Rationale for a Randomized Trial of Prophylactic Cranial Irradiation With or Without Hippocampal Avoidance for SCLC: PREMER Trial on Behalf of the Oncologic Group for the Study of Lung Cancer/Spanish Radiation Oncology Group-Radiation Oncology Clinical Research Group.
Rodríguez de Dios N; Couñago F; López JL; Calvo P; Murcia M; Rico M; Vallejo C; Luna J; Trueba I; Cigarral C; Farre N; Manero RM; Durán X; Samper P
Clin Lung Cancer; 2018 Sep; 19(5):e693-e697. PubMed ID: 29891263
[TBL] [Abstract][Full Text] [Related]
37. Is prophylactic cranial irradiation (PCI) needed in patients with extensive-stage small cell lung cancer showing complete response to first-line chemotherapy?
Nosaki K; Seto T; Shimokawa M; Takahashi T; Yamamoto N
Radiother Oncol; 2018 Jun; 127(3):344-348. PubMed ID: 29747871
[TBL] [Abstract][Full Text] [Related]
38. Health-related quality of life after prophylactic cranial irradiation for stage III non-small cell lung cancer patients: Results from the NVALT-11/DLCRG-02 phase III study.
Witlox WJA; Ramaekers BLT; Joore MA; Dingemans AC; Praag J; Belderbos J; Tissing-Tan C; Herder G; Haitjema T; Ubbels JF; Lagerwaard J; El Sharouni SY; Stigt JA; Smit EF; van Tinteren H; van der Noort V; Groen HJM; De Ruysscher DKM
Radiother Oncol; 2020 Mar; 144():65-71. PubMed ID: 31733490
[TBL] [Abstract][Full Text] [Related]
39. Impact of Early Prophylactic Cranial Irradiation With Hippocampal Avoidance on Neurocognitive Function in Patients With Limited Disease Small Cell Lung Cancer. A Multicenter Phase 2 Trial (SAKK 15/12).
Vees H; Caparrotti F; Eboulet EI; Xyrafas A; Fuhrer A; Meier U; Mark M; Elicin O; Aebersold DM; Zwahlen DR; Finazzi T; Allal AS; Putora PM; Martucci F; Rudolf CB; Ribi K;
Int J Radiat Oncol Biol Phys; 2020 Jun; 107(2):279-287. PubMed ID: 32142869
[TBL] [Abstract][Full Text] [Related]
40. Neurochemical evidence of potential neurotoxicity after prophylactic cranial irradiation.
Kalm M; Abel E; Wasling P; Nyman J; Hietala MA; Bremell D; Hagberg L; Elam M; Blennow K; Björk-Eriksson T; Zetterberg H
Int J Radiat Oncol Biol Phys; 2014 Jul; 89(3):607-14. PubMed ID: 24803034
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
